Rejected Device Applicants Conserve R&D Resources, Sidestep Confrontation
This article was originally published in The Gray Sheet
Executive Summary
Implantable device manufacturers who encountered FDA resistance in 2004 after favorable panel reviews are applying novel premarket data collection techniques to avoid conducting further clinical trials